Cellebrite vs Meiya Pico
Cellebrite holds the stronger position because it is growing and profitable while Meiya Pico is losing more money each year despite government backing.
Cellebrite
Cellebrite makes forensic tools that extract and analyze data from phones for police and governments
Meiya Pico
Chinese state-owned firm that extracts phone data for police forensic investigations
Dimension by dimension
| Dimension | Cellebrite | Meiya Pico |
|---|---|---|
| Staying power of the core product | Forensic data extraction tools for police and governments worldwide, with revenue and subscriptions both climbing. | State-backed forensics supplier to Chinese police, but three straight years of widening losses raise doubts about its footing. |
| Exposure to AI | AI is seen as unlikely to absorb its product. | AI-driven tools are partly eating into the value of its forensic software, even inside its protected home market. |
| How easily a giant copies them | Blocked from easy copying as well. | Blocked from easy copying, given its state-backed position in China. |
| Pressure from rivals | No meaningful customer loss shows up in the evidence. | Faces domestic rivals like iFlytek and Venustech, plus AI tools chipping at its value, even with government protection. |
| Financial footing | Q1 2026 revenue hit $128.3 million, up 19% year over year, with subscription revenue up 23% and total ARR up 21%. | Net income has worsened every year, from -¥206 million in 2023 to -¥782 million in 2025. |
| Overall market position | Considered durable as of this July 2026 assessment, backed by consistent revenue growth, rising subscription revenue, and expanding ARR through Q1 2026. | Considered fragile as of this July 2026 assessment, with losses that have widened for three consecutive years despite state backing. |
Questions people ask
- Meiya Pico vs Cellebrite, which is more built to last?
- Cellebrite is rated hard to displace while Meiya Pico is rated losing its protection. Cellebrite is growing revenue and subscriptions, while Meiya Pico's net losses have widened for three consecutive years.
- Is Meiya Pico losing money?
- Yes. Meiya Pico's net income went from -¥206 million in 2023 to -¥415 million in 2024 to -¥782 million in 2025, a worsening trend each year. Cellebrite, by contrast, reported growing quarterly revenue and ARR in its most recent report.
- Which company faces more competitive pressure, Meiya Pico or Cellebrite?
- Meiya Pico faces more pressure, from domestic rivals like iFlytek and Venustech plus AI tools eroding its forensic software value, even inside its protected China market. Cellebrite shows no meaningful customer loss in the evidence available.
- How exposed is each company to AI replacing its product?
- Meiya Pico is partly exposed, with AI-driven tools already eating into its forensic software's value. Cellebrite is rated unlikely to be absorbed by AI, giving it an edge on this point.
- Can a big tech giant easily copy Meiya Pico or Cellebrite?
- Both are rated as blocked from easy copying by a giant. Meiya Pico benefits from state backing in China, and Cellebrite holds a similarly protected position in its market.